Poly-ubiquitin profile in Alzheimer disease brain

Alzheimer disease (AD) is a neurodegenerative disorder characterized by progressive loss of memory, reasoning and other cognitive functions. Pathologically, patients with AD are characterized by deposition of senile plaques (SPs), formed by β-amyloid (Aβ), and neurofibrillary tangles (NTFs) that con...

Full description

Bibliographic Details
Main Authors:	Antonella Tramutola, Francesca Triani, Fabio Di Domenico, Eugenio Barone, Jian Cai, Jon B. Klein, Marzia Perluigi, D. Allan Butterfield
Format:	Article
Language:	English
Published:	Elsevier 2018-10-01
Series:	Neurobiology of Disease
Subjects:	Polyubiquintinylation Alzheimer disease brain Proteomics Contribution to neurodegeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996118302110

Similar Items

Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
by: Antonella Tramutola, et al.
Published: (2020-04-01)

It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease
by: Antonella Tramutola, et al.
Published: (2016-01-01)

The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
by: Marzia Perluigi, et al.
Published: (2020-08-01)

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
by: Antonella Tramutola, et al.
Published: (2018-11-01)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
by: Jakob M Bader, et al.
Published: (2020-06-01)

Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
by: Nidhi Sharma, et al.
Published: (2019-05-01)

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease
by: Tanea Reed, et al.
Published: (2008-04-01)

The ubiquitin–proteasome system in Creutzfeldt–Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability
by: Csaba Ádori, et al.
Published: (2005-08-01)

Multiple Herpes Simplex Virus-1 (HSV-1) Reactivations Induce Protein Oxidative Damage in Mouse Brain: Novel Mechanisms for Alzheimer’s Disease Progression
by: Virginia Protto, et al.
Published: (2020-06-01)

High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer’s Disease Signatures
by: Ilaria Zuliani, et al.
Published: (2021-04-01)

Proteomic Techniques to Examine Neuronal Translational Dynamics
by: Shon A. Koren, et al.
Published: (2019-07-01)

mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy
by: Marzia Perluigi, et al.
Published: (2015-12-01)

Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?
by: Eugenio Barone, et al.
Published: (2015-12-01)

BrightFocus Alzheimer’s Fast Track 2019
by: Keith W. Whitaker, et al.
Published: (2019-12-01)

Proteomics Landscape of Alzheimer’s Disease
by: Ankit P. Jain, et al.
Published: (2021-03-01)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
by: Francesca Romana Buccellato, et al.
Published: (2021-08-01)

Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
by: Sofia Toniolo, et al.
Published: (2020-12-01)

Mitochondrial Manipulation and the Quest for Alzheimer's Treatments
by: Russell H. Swerdlow
Published: (2015-04-01)

Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
by: Srikant Rangaraju, et al.
Published: (2018-06-01)

An attempt to elucidate the role of iron and zinc ions in development of Alzheimer’s and Parkinson’s diseases
by: Karolina Wojtunik-Kulesza, et al.
Published: (2019-03-01)

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
by: D. Allan Butterfield, et al.
Published: (2020-09-01)

Alzheimer disease neuropathology:understanding autonomic dysfunction
by: Eliasz Engelhardt, et al.

Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
by: Daniela Liccardo, et al.
Published: (2020-07-01)

GSK3 and Alzheimer's disease: facts & fiction …
by: Fred eVanleuven
Published: (2011-08-01)

Alzheimer’s disease prevention – The emerging role of lipids and diet
by: Hartmann Tobias, et al.
Published: (2007-05-01)

Sleep disorders and Alzheimer’s disease
by: A. N. Bogolepova
Published: (2018-04-01)

Microglial Immunometabolism in Alzheimer’s Disease
by: Daniel C. Shippy, et al.
Published: (2020-09-01)

The role of sirtuins in Alzheimer’s Disease
by: Rakhee eLalla, et al.
Published: (2013-04-01)

New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
by: Airton Cunha Martins, et al.
Published: (2019-09-01)

Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
by: Marzia Perluigi, et al.
Published: (2012-01-01)

NEW ROLES FOR FC RECEPTORS IN NEURODEGENERATION-THE IMPACT ON IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE
by: James P. Fuller, et al.
Published: (2014-08-01)

Entanglement of CCR5 and Alzheimer’s Disease
by: Tianwen Li, et al.
Published: (2019-08-01)

The Eye as a Biomarker for Alzheimer’s Disease
by: Jeremiah Kah Heng Lim, et al.
Published: (2016-11-01)

Molecular and Functional Interaction of the Myokine Irisin with Physical Exercise and Alzheimer’s Disease
by: Yunho Jin, et al.
Published: (2018-12-01)

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
by: Luca eSteardo, et al.
Published: (2015-07-01)

Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
by: Ajay K Singh, et al.
Published: (2020-01-01)

Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors
by: Alžběta Kračmarová, et al.
Published: (2015-08-01)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
by: Lara Ordóñez-Gutiérrez, et al.
Published: (2020-05-01)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
by: Ricardo F. Allegri, et al.
Published: (2020-01-01)

Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
by: Carsten Esselun, et al.
Published: (2021-08-01)